Cargando…
Nanotechnology against human cytomegalovirus in vitro: polyanionic carbosilane dendrimers as antiviral agents
BACKGROUND: Human cytomegalovirus (HCMV) is a worldwide infection, causing different troublesome in immunosupressed patients and very related to Human Immunodeficiency Virus 1 (HIV-1) infection, mainly in developing countries, with a co-infection rate of 80% in Africa. The high cost of present treat...
Autores principales: | Relaño-Rodríguez, I., Espinar-Buitrago, M. S., Martín-Cañadilla, V., Gómez-Ramirez, R., Jiménez, J. L., Muñoz-Fernández, M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927225/ https://www.ncbi.nlm.nih.gov/pubmed/33658029 http://dx.doi.org/10.1186/s12951-021-00809-4 |
Ejemplares similares
-
G2-S16 Polyanionic Carbosilane Dendrimer Can Reduce HIV-1 Reservoir Formation by Inhibiting Macrophage Cell to Cell Transmission
por: Relaño-Rodríguez, Ignacio, et al.
Publicado: (2021) -
Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-1
por: Vacas-Córdoba, Enrique, et al.
Publicado: (2016) -
Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment
por: Relaño-Rodríguez, Ignacio, et al.
Publicado: (2019) -
Emergence of Nanotechnology to Fight HIV Sexual Transmission: The Trip of G2-S16 Polyanionic Carbosilane Dendrimer to Possible Pre-Clinical Trials
por: Relaño-Rodríguez, Ignacio, et al.
Publicado: (2020) -
Efficacy of HIV antiviral polyanionic carbosilane dendrimer G2-S16 in the presence of semen
por: Ceña-Diez, Rafael, et al.
Publicado: (2016)